130例酒精性肝衰竭患者临床特点与预后分析

doi:10.3969/j.issn.1672-5069.2014.02.007

摘要/Abstract

摘要： 目的分析酒精性肝衰竭患者临床特点及预后影响因素。方法回顾性分析2004年1月至2013年5月住解放军第302医院的资料完整的130例酒精性肝衰竭患者的临床特点及预后影响因素。结果酒精性肝衰竭患者的诱发因素为感染（52.3%）、短期过度饮酒（8.5%）、疲劳（3.8%）、情绪激动（0.8%），另有34.6%原因不明；酒精性肝衰竭患者治愈或好转率为41.5%，无效率为42.3%，死亡率为16.1%，其中死亡前4位的原因分别为肝性脑病和脑水肿或脑疝（33.3%）、感染性休克（28.6%）、失血性休克（23.8%）和肝肾综合征（9.5%）；无效或死亡患者脑水肿、脑疝和肝肾综合征的发生率分别为14%、7%和36%，显著高于治愈或好转患者[分别为1%、1%和6%，P均<0.01）]；无效或死亡患者血红蛋白水平[（85.0±28.3） g/L]显著低于治愈或好转组[（95.2±27.6）g/L，P<0.05）]；无效或死亡患者Maddrey判别函数、MELD评分和Glasgow评分分别为（94.56±63.17）、（25.52±8.29）和（9.76±1.04），均显著高于治愈或好转患者[分别为（68.24±24.61）、（19.03±10.13）和（9.30±1.11），P均<0.01）]；凝血酶原时间（r=-0.19，P=0.03）、国际标准化比值（r=-0.21，P=0.02）、尿素氮（r=-0.28，P=0.01）和肌酐（r=-0.28，P=0.01）水平与预后均呈负相关关系（P<0.05或P<0.01），患者出现脑水肿（r=-0.26，P=0.01）、脑疝（r=-0.26，P=0.01）和肝肾综合征（r=-0.38，P=0.01）均与预后呈负相关（P<0.01）。结论酒精性肝衰竭的常见诱发因素为感染和短期过量饮酒，凝血功能、肾功能和脑功能障碍是预后不良的重要预测因素。

关键词: 酒精性肝衰竭, 临床特点, 预后因素, 感染

Abstract: Objective To investigate the clinical features and prognosis of patients with alcoholic liver failure. Methods The clinical features and prognosis in 130 patients with alcoholic liver failure who had admitted to Beijing 302nd Hospital of PLA from January 2004 to May 2013 were retrospectively analyzed. Results The precipitating factors of patients with alcoholic liver failure were concurrent infection（52.3%），short-term excessive drinking （8.5%），fatigue （3.8%），emotional change （0.8%） and unknown cause （34.6%）; The curative or improvement rate of patients with alcoholic liver failure was 41.5%，the nonresponsive to treatment was 42.3%，and the mortality rate was 16.2%；Hepatic encephalopathy and cerebral edema or cerebral hernia（33.3%），septic shock （28.6%），hemorrhagic shock （23.8%） and hepatorenal syndrome （9.5%） were the top four causes of death；The incidence of cerebral edema，cerebral hernia，hepatorenal syndrome in nonresponsive or death patients were 14%，7% and 36% respectively，significantly higher than those in improved patients （1%，1% and 6%，respectively，P<0.01）；The blood hemoglobin levels in nonresponsive or death patients[（85.0± 28.3）g/L]was significantly lower than that in improved patients[（95.2±27.6） g/L，P<0.05]；The Maddrey's discriminant function，MELD score and Glasgow score in nonresponsive or death patients were （94.56±63.17），（25.52±8.29）and（9.76±1.04），respectively，significantly higher than those in improved patients [（68.24±24.61），（19.03±10.13）and（9.30±1.11），P<0.01]；Prothrombin time （r=-0.19，P=0.03），international normalized ratio （r=-0.21，P=0.02），blood urea nitrogen （r=-0.28，P=0.01） and creatinine （r=-0.28，P=0.01） were negatively correlated with the prognosis of patients（P<0.05 or P<0.01）；Patients with cerebral edema （r=-0.26，P=0.01），cerebral hernia （r=-0.26，P=0.01） and hepatorenal syndrome （r=-0.38，P=0.01）were negatively correlated with the prognosis（P<0.01）. Conclusions The common precipitating factors of patients with alcoholic liver failure are concurrent infection and short-term excessive drinking. Coagulation， kidney and brain dysfunction are important predictors for poor prognosis.

Key words: Alcoholic liver failure, Clinical features, Prognosis, Infection

郝书理，李保森，孙颖，常彬霞，滕光菊，赵军，张伟，邹正升. 130例酒精性肝衰竭患者临床特点与预后分析[J]. 实用肝脏病杂志, 2014, 17(2): 136-140.

Hao Shuli，Li Baosen，Sun Ying，et al.. Clinical features and prognosis in 130 patients with alcoholic liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 136-140.

参考文献

[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南. 临床肝胆病杂志，2010，26（3）:229-232.
[2] European Association for the Study of Liver. EASL Clinical Practical Guidelines: management of alcoholic liver disease. J Hepatol，2012，57（2）:399-420.
[3] Lucey MR，Mathurin P，Morgan TR. Alcoholic hepatitis. N Engl J Med，2009，360（26）:2758-2769.
[4] O'Shea RS，Dasarathy S，McCullough AJ. Alcoholic liver disease. Hepatology，2010，51（1）:307-328.
[5] Mathurin P，Louvet A，Duhamel A，et al. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis:a randomized clinical trial. JAMA，2013，310（10）:1033-1041
[6] Halegoua-De Marzio DL，Fenkel JM.Treatment of severe alcoholic hepatitis with corticosteroids and pentoxifylline. JAMA，2013，310（10）:1029-1030.
[7] Forrest E，Mellor J，Stanton L，et al. Steroids or pentoxifylline for alcoholic hepatitis（STOPAH）:study protocol for a ran domised controlled trial. Trials，2013，14（1）:262.
[8] Potts JR，Goubet S，Heneghan MA，et al. Determinants of long-term outcome in severe alcoholic hepatitis.Aliment Pharmacol Ther，2013，38（6）:584-595.
[9] Potts JR，Howard MR，Verma S. Recurrent severe alcoholic hepatitis:clinical characteristics and outcomes.Eur J Gastroenterol Hepatol，2013，25（6）:659-664.
[10] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组. 肝衰竭诊疗指南. 实用肝脏病杂志，2006，9（6）：321-324.
[11] Katoonizadeh A，Laleman W，Verslype C，et al. Early features of acute-on-chronic alcoholic liver failure:a prospective cohort study. Gut，2011，59（11）:1561-1569.
[12] Sohail U，Satapathy SK. Diagnosis and management of alcoholic hepatitis. Clin Liver Dis，2012，16（4）:717-736.
[13] Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis，2005，9（1）:37-53.
[14] Ishak KG，Zimmerman HJ，Ray MB. Alcoholic liver disease: pathologic，pathogenetic and clinical aspects. Alcohol Clin Exp Res，1991，15（1）:45-66.
[15] Forrest EH，Evans CD，Stewart S，et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut，2005，54:1174-1179.
[16] Forrest EH，Morris AJ，Stewart S，et al. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut，2007，56:1743-1746.
[17] Guha IN，Rosenberg WM. Future use of the Glasgow alcoholic hepatitis score. Gut. 2006，55（1）:135-136.
[18] Dunn W，Jamil LH，Brown LS，et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology，2005，41:353-358.
[19] Srikureja W，Kyulo NL，Runyon BA，et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant function score in patients with alcoholic hepatitis. J Hepatol，2005，42:700-706.
[20] Forrest EH. Prognostic evaluation of alcoholic hepatitis.J Hepatol，2005，43（4）:738-739.